These results suggested that the signalling pathway repressing NASH-induced liver tumours in male Bcl6-LKO mice is regulated by the repression of IL6 production and Bcl6-related mechanisms regulating gender-different liver functional genes. The gene discussed is IL6; the disease is metabolic dysfunction-associated steatohepatitis.